Evidence map›Paper›PMID 36217330›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2022

Re-Defining High Risk COPD with Parameter Response Mapping Based on Machine Learning Models.

Yu Pu, Xiuxiu Zhou, Di Zhang, Yu Guan, Yi Xia, Wenting Tu, Yang Lu, Weidong Zhang, Chi-Cheng Fu, Qu Fang and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A CT-Based Lung Radiomics Nomogram for Classifying the Severity of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2024
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Yu Pu *Department of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0002-3649-6779
Xiuxiu Zhou *Department of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-2405-0566
Di Zhang *Department of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-4309-8098
Yu Guan *Department of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0001-9416-058X
Yi XiaDepartment of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0002-7117-8995
Wenting TuDepartment of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-1010-7189
Yang LuDepartment of Scientific Research, Shanghai Aitrox Technology Corporation Limited, Shanghai, People's Republic of China.ORCID 0000-0002-3841-2858
Weidong ZhangDepartment of Scientific Research, Shanghai Aitrox Technology Corporation Limited, Shanghai, People's Republic of China.ORCID 0000-0002-5429-5700
Chi-Cheng FuDepartment of Scientific Research, Shanghai Aitrox Technology Corporation Limited, Shanghai, People's Republic of China.ORCID 0000-0001-8846-3808
Qu FangDepartment of Scientific Research, Shanghai Aitrox Technology Corporation Limited, Shanghai, People's Republic of China.ORCID 0000-0001-7081-0904
Geertruida H de BockDepartment of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands.ORCID 0000-0003-3104-4471
Shiyuan LiuDepartment of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-4402-0540
Li FanDepartment of Radiology, Changzheng Hospital, Naval Medical University, Shanghai, People's Republic of China.ORCID 0000-0003-4722-3933
Shanghai Changzheng Hospital · CNUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To explore optimal threshold of FEV1% predicted value (FEV1%pre) for high-risk chronic obstructive pulmonary disease (COPD) using the parameter response mapping (PRM) based on machine learning classification model. Patients and Methods: A total of 561 consecutive non-COPD subjects who were screened for chest diseases in our hospital between August and October 2018 and who had complete questionnaire surveys, pulmonary function tests (PFT), and paired respiratory chest CT scans were enrolled retrospectively. The CT quantitative parameter for small airway remodeling was PRM, and 72 parameters were obtained at the levels of whole lung, left and right lung, and five lobes. To identify a more reasonable thresholds of FEV1% predicted value for distinguishing high-risk COPD patients from the normal, 80 thresholds from 50% to 129% were taken with a partition of 1% to establish a random forest classification model under each threshold, such that novel PFT-parameter-based high-risk criteria would be more consistent with the PRM-based machine learning classification model. Results: Machine learning-based PRM showed that consistency between PRM parameters and PFT was better able to distinguish high-risk COPD from the normal, with an AUC of 0.84 when the threshold was 72%. When the threshold was 80%, the AUC was 0.72 and when the threshold was 95%, the AUC was 0.64. Conclusion: Machine learning-based PRM is feasible for redefining high-risk COPD, and setting the optimal FEV1% predicted value lays the foundation for redefining high-risk COPD diagnosis.

Indexed as

Pulmonary Disease, Chronic ObstructiveHumansLungMachine LearningRespiratory Function TestsRetrospective Studiesartificial intelligencechronic obstructive pulmonary diseasecomputed tomographypulmonary function testquantitative imaging

Identifiers

PMID36217330
PMCPMC9547550
OpenAlexW4301396565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.